DOI QR코드

DOI QR Code

Immune Responses Induced by HSP60 DNA Vaccine against Toxoplasma gondii Infection in Kunming Mice

  • Li, Zhong-Yuan (College of Animal Science and Technology, Anhui Agricultural University) ;
  • Lu, Jing (Guangdong Wens Dahuanong Biotechnology Co., Ltd) ;
  • Zhang, Nian-Zhang (State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences) ;
  • Chen, Jia (Ningbo University School of Medicine) ;
  • Zhu, Xing-Quan (State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences)
  • Received : 2018.02.09
  • Accepted : 2018.04.23
  • Published : 2018.06.30

Abstract

Toxoplasma gondii can infect all the vertebrates including human, and leads to serious toxoplasmosis and considerable veterinary problems. T. gondii heat shock protein 60 (HSP60) is associated with the activation of antigen presenting cells by inducing initial immune responses and releasing inflammatory cytokines. It might be a potential DNA vaccine candidate for this parasite. A pVAX-HSP60 DNA vaccine was constructed and immune responses was evaluated in Kunming mice in this study. Our data indicated that the innate and adaptive immune responses was elicited by successive immunizations with pVAX-HSP60 DNA, showing apparent increases of CD3e+CD4+ and CD3e+CD8a+ T cells in spleen tissues of the HSP60 DNA-immunized mice ($24.70{\pm}1.23%$ and $10.90{\pm}0.89%$, P<0.05) and higher levels of specific antibodies in sera. Furthermore, the survival period of the immunized mice ($10.53{\pm}4.78day$) were significantly prolonged during the acute T. gondii infection. Decrease of brain cysts was significant in the experimental group during the chronic infection (P<0.01). Taken together, TgHSP60 DNA can be as a vaccine candidate to prevent the acute and chronic T. gondii infections.

Keywords

References

  1. Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D. Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev 2010; 23: 795-836. https://doi.org/10.1128/CMR.00001-10
  2. Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update 2016; 22: 116-133. https://doi.org/10.1093/humupd/dmv041
  3. Alday PH, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther 2017; 11: 273-293. https://doi.org/10.2147/DDDT.S60973
  4. Mattoo RU, Goloubinoff P. Molecular chaperones are nanomachines that catalytically unfold misfolded and alternatively folded proteins. Cell Mol Life Sci 2014; 71: 3311-3325. https://doi.org/10.1007/s00018-014-1627-y
  5. Finka A, Sharma SK, Goloubinoff P. Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70/HSP110 chaperones. Front Mol Biosci 2015; 2: 29.
  6. Bar-Lavan Y, Shemesh N, Ben-Zvi A. Chaperone families and interactions in metazoa. Essays Biochem 2016; 60: 237-253. https://doi.org/10.1042/EBC20160004
  7. Binder RJ. Functions of heat shock proteins in pathways of the innate and adaptive immune system. J Immunol 2014; 193: 5765-5771. https://doi.org/10.4049/jimmunol.1401417
  8. Juwono J, Martinus RD. Does hsp60 provide a link between mitochondrial stress and inflammation in diabetes mellitus? J Diabetes Res 2016; 2016: 8017571.
  9. Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S. Heat shock proteins and cancer. Trends Pharmacol Sci 2017; 38: 226-256. https://doi.org/10.1016/j.tips.2016.11.009
  10. Toursel C, Dzierszinski F, Bernigaud A, Mortuaire M, Tomavo S. Molecular cloning, organellar targeting and developmental expression of mitochondrial chaperone HSP60 in Toxoplasma gondii. Mol Biochem Parasitol 2000; 111: 319-332. https://doi.org/10.1016/S0166-6851(00)00324-8
  11. Ma GY, Zhang JZ, Yin GR, Zhang JH, Meng XL, Zhao F. Toxoplasma gondii: proteomic analysis of antigenicity of soluble tachyzoite antigen. Exp Parasitol 2009; 122: 41-46. https://doi.org/10.1016/j.exppara.2009.01.011
  12. Wang F, Liu F, Liu H, Chen W, Si X, Ma X. Effects of immunological and hematological parameter in mice exposed to mixture of volatile organic compounds. Inhal Toxicol 2016; 28: 164-169. https://doi.org/10.3109/08958378.2016.1148087
  13. Li ZY, Chen J, Petersen E, Zhou DH, Huang SY, Song HQ, Zhu XQ. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014; 32: 3058-3065. https://doi.org/10.1016/j.vaccine.2014.03.042
  14. Zhang NZ, Xu Y, Wang M, Petersen E, Chen J, Huang SY, Zhu XQ. Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines 2015; 14: 1289-1297. https://doi.org/10.1586/14760584.2015.1061938
  15. Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, Zhou Y, Yang GL, Zhu XQ. Evaluation of protective effect of pVAX-Tg-MIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine 2013; 31: 3135-3139. https://doi.org/10.1016/j.vaccine.2013.05.040
  16. Ota Y, Ishihara S, Otani K, Yasuda K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T. Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes. Mol Clin Oncol 2016; 4: 607-610. https://doi.org/10.3892/mco.2016.763
  17. Kur J, Holec-Gasior L, Hiszczynska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 2009; 8: 791-808. https://doi.org/10.1586/erv.09.27
  18. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009; 39: 895-901. https://doi.org/10.1016/j.ijpara.2009.02.004
  19. Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol 2014; 14: 109-121. https://doi.org/10.1038/nri3598
  20. Burrells A, Benavides J, Canton G, Garcia JL, Bartley PM, Nath M, Thomson J, Chianini F, Innes EA, Katzer F. Vaccination of pigs with the S48 strain of Toxoplasma gondii--safer meat for human consumption. Vet Res 2015; 46: 47. https://doi.org/10.1186/s13567-015-0177-0
  21. Ching XT, Fong MY, Lau YL. Evaluation of immunoprotection conferred by the subunit vaccines of GRA2 and GRA5 against acute toxoplasmosis in BALB/c mice. Front Microbiol 2016; 7: 609.
  22. Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 2016; 15: 313-329.
  23. Han Y, Zhou A, Lu G, Zhao G, Sha W, Wang L, Guo J, Zhou J, Zhou H, Cong H, He S. DNA vaccines encoding Toxoplasma gondii cathepsin C1 induce protection against toxoplasmosis in mice. Korean J Parasitol 2017; 55: 505-512. https://doi.org/10.3347/kjp.2017.55.5.505
  24. Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ. DNA immunization with eukaryotic initiation factor-$2{\alpha}$ of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine 2013; 31: 6225-6231. https://doi.org/10.1016/j.vaccine.2013.10.034
  25. Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, Zhu XQ. Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infect Dis 2014; 14: 525. https://doi.org/10.1186/1471-2334-14-525
  26. Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 2012; 34: 793-813. https://doi.org/10.1007/s00281-012-0339-3
  27. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994; 153: 2533-2543.
  28. Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull 2009; 35: 1163-1182. https://doi.org/10.1093/schbul/sbn054
  29. Davidson MG. Toxoplasmosis. Vet Clin North Am Small Anim Pract 2000; 30: 1051-1062. https://doi.org/10.1016/S0195-5616(00)05006-3
  30. Kolinski T, Marek-Trzonkowska N, Trzonkowski P, Siebert J. Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs). Cent Eur J Immunol 2016; 41: 317-323.

Cited by

  1. Review of DNA Vaccine Approaches Against the Parasite Toxoplasma gondii vol.107, pp.6, 2018, https://doi.org/10.1645/20-157